MORGAN STANLEY PLC/CALL/STRYKER CORP./330/0.1/20.12.24 Stock

Warrant

DE000MB35HA9

Real-time Bid/Ask 11:57:26 2024-06-27 EDT
2.93 EUR / 2.97 EUR -1.99% Intraday chart for MORGAN STANLEY PLC/CALL/STRYKER CORP./330/0.1/20.12.24
Current month+0.67%
1 month+6.74%
Date Price Change
24-06-27 3.11 +3.32%
24-06-26 3.01 +7.12%
24-06-25 2.81 -7.26%
24-06-24 3.03 -0.98%
24-06-21 3.06 -3.77%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 10:20 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN MB35HA
ISINDE000MB35HA9
Date issued 2023-02-02
Strike 330 $
Maturity 2024-12-20 (176 Days)
Parity 10 : 1
Emission price 2.29
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.19
Lowest since issue 1.03
Spread 0.04
Spread %1.33%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
340.5 USD
Average target price
372.9 USD
Spread / Average Target
+9.52%
Consensus